Introduction {#s1}
============

The population of older adults in Mexico is one of the most rapidly growing in the world.[@R1] Life expectancy (LE) has risen rapidly over the last half-century, and currently, stands at 79 years for females and 73 years for males,[@R1] up from 50 and 47 years, respectively, in 1950. In Mexico, and throughout Latin America, population ageing is occurring at a much faster pace than economic development, resulting in severe restrictions on the pool of resources available to care for older adults.[@R2] Providing care and support for this growing elderly population is one of the largest public health challenges facing Latin America today.[@R3]

Though the long-term trend in survival of older Mexicans shows marked improvements, a growing body of evidence finds a recent pattern of declining health and increasing chronic conditions among older adults. The prevalence of hypertension, diabetes and hypercholesterolaemia all increased markedly in prevalence among older individuals between 2000 and 2012,[@R4] and diabetes prevalence among those aged 60+ years has continued to rise.[@R5] Rising trends in obesity have been implicated in a substantial burden of excess mortality among the population aged 60+ years,[@R6] and are projected to have negative effects on future trends in LE.[@R7] Rates of dementia incidence are high in Mexico compared with higher-income populations,[@R8] and dementia cases are set to rise rapidly across Latin America in the coming decades due to demographic and health transitions.[@R9] Gains in LE have also stagnated in Mexico, in recent years, due to persistently high rates of interpersonal violence and a rapid increase in obesity and diabetes mellitus.[@R10]

In the classical epidemiological transition, expansion in LE was thought to result in a compression of disability to a smaller portion of late life, with medical advances and improved health behaviours increasing the age of onset of morbidity or disability more quickly than rises in LE.[@R14] Evidence suggests that this compression is broadly occurring in many high-income contexts,[@R15] though evidence is mixed in the USA, particularly at late-middle ages.[@R19] A different theoretical viewpoint, predicting an expansion of disability or morbidity, has also been put forward.[@R22] This theory posits that reductions in early-life mortality may lead individuals with worse health to survive longer than they would have in the past. This second viewpoint needs consideration in the case of Mexico. Prior research on Latin America has found that over half of the post-1945 mortality decline was associated directly with the adoption of medical technologies that reduced infant and child mortality (eg, antibiotics, vaccination and pesticides for malaria control), as opposed to resulting from broad social and economic development.[@R23] This legacy of improved survivorship, but slow development, may lead to successive cohorts at higher risk of morbidity and disability in Latin America, as the delayed effects of poor childhood conditions have a lasting imprint on underlying health.[@R24] Indeed, the continued effects of these poor early-life conditions may in part be behind the rapid rises in cardiovascular disease, obesity and diabetes observed in the region.[@R27]

In this paper, we use data from the Mexican Health and Aging Study (MHAS), a long-running longitudinal sample survey of older adults in Mexico,[@R29] to examine whether successive birth cohorts in the Mexican population are living more of their life with physical limitations and/or disability. Our analyses focus on measuring disability-free LE (DFLE) across birth cohorts in the Mexican population. DFLE distinguishes between years that are free of limitations and years with activity limitations or disability, providing a metric that combines mortality and disability into a single measure. We compare cohort changes in disability and longevity using data from two distinct periods (2001--2003 and 2012--2015) to understand whether the Mexican population is experiencing a compression or expansion of disability.

Methods {#s2}
=======

Study participants {#s2-1}
------------------

Data came from the MHAS.[@R29] MHAS is a Health and Retirement Study, sister study of adults aged 50+ years, with waves of data in 2001, 2003, 2012 and 2015. Our analyses use individuals who were interviewed in both 2001 and 2003 or who died between waves (N=14 250, response rate 93%), and individuals who were interviewed in both 2012 and 2015 or who died between waves (N=15 168, response rate 88%). A refresher sample of 6259 new individuals (primarily aged 50--59) was added in 2012.

Measures {#s2-2}
--------

We conceptualise disability within the framework of the disablement process,[@R30] with disability defined as a gap between an individual's capacities and the demands of a given activity. Individuals are classified as **physically limited** if they report difficulty on one or more of the following seven physical activities: walking a block, sitting for 2 hours, getting up from a chair, climbing a flight of stairs, kneeling or crouching, pushing or pulling a heavy object, or carrying heavy (5 kg) objects. Individuals are classified as **activities of daily living (** **ADL) disabled** if they report difficulty or inability to do any of the following five activities: bathing, eating, getting in/out of bed, toileting and walking across a room.[@R31] Where necessary, proxy responses on ADL disability are used. Proxy respondents were not asked the physical activity questions; individuals requiring the assistance of a proxy for health reasons were assumed to be physically limited if the proxy did not report an ADL disability. Individuals who report both physical limitations and ADL disabilities are classified as ADL disabled. Individuals who reported no physical limitations or ADL disabilities are classified as **active**.

Statistical analyses {#s2-3}
--------------------

Prior research on population-level disability in low-income and middle-income countries has relied largely on period comparisons---that is, measuring mortality and disability conditions in a population at different points in time, and observing changes in the trends over time. However, tracking disability using only period estimates may obscure substantial heterogeneity in trends between birth cohorts, and provides limited information on how trends in DFLE have shifted over time and across cohorts. Measuring cohort changes in disability provides results that match more closely with the lived experience of individuals in a population,[@R32] and prior work has found relatively poor correspondence between measures of period and cohort DFLE.[@R33]

Our analyses compare LE and DFLE across successive 10-year birth cohorts in three bounded 10-year age ranges---ages 50--59, 60--69 and 70--79. These estimates are also known as 'partial' or 'temporary' LE. [Online supplemental figure 1](#SP1){ref-type="supplementary-material"} displays a Lexis diagram showing this comparison graphically for estimating DFLE in ages 50--59 for those born in 1942--1951 (who were aged 50--59 in the 2001 MHAS) and those born in 1953--1962 (the new sample of 50--59 year-olds added in the 2012 MHAS). We model the conditional annual probability of experiencing a transition between the four modelled states (active, physically limited, ADL disabled and deceased) as a function of age and gender, separately by birth cohort and observation period (2001--2003 and 2012--2015, outlined in the dark dashed line), using a cumulative logistic regression model with a relaxed proportional odds assumption on gender,[@R34] and stratified by initial health state. Transitions between health states are assumed to occur at a random time between observations. Transition probability estimates were obtained using PROC SURVEYLOGISTIC in SAS V.9.4. In all analyses, in this paper, the cohorts are distinct---that is, there are no individuals contributing person-years of observation to the two different cohorts compared in each age-range.
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These observed transition probabilities are then used as the input for a microsimulation-based multistate life table model.[@R35] To calculate LE and DFLE, we create synthetic cohorts of 100 000 individuals with the same initial gender and health state distribution as the study population in a given age-range and cohort. We then 'age' these individuals forward year by year via microsimulation, applying the age-specific and gender-specific mortality rates and probabilities of transitioning in and out of disability estimated from the data. This process is then repeated until the end of the age-range under study---that is, when investigating DFLE for a given cohort in ages 50--59, the model will microsimulate the life-courses of 100 000 individuals starting at age 50 and ending at exact age 60. The resulting synthetic cohort is analysed to estimate active, limited, ADL disabled and total LE. Point estimates shown are from transition probabilities estimated from the full sample. CIs, which reﬂect both the uncertainty of the estimated parameters and the uncertainty from the microsimulation, were created by re-estimating the above analysis sequence using 499 bootstrap re-samples from each birth cohort under study. We took the central 95% of the distribution of these bootstrapped parameters as our 95% CI, and calculated non-parametric p values for differences in means between birth cohorts.[@R38] We include inverse-probability (IP) weights to correct for potential bias introduced from differential loss to follow-up. The weight generating model includes all sociodemographic and health variables included in [online supplementary table 1](#SP1){ref-type="supplementary-material"} and the cross-sectional survey sampling weight.[@R39] IP weights were generated separately for each age group and cohort included in these analyses.

Results {#s3}
=======

[Online supplementary table 1](#SP1){ref-type="supplementary-material"} presents the sociodemographic and health characteristics of the MHAS population at the two baseline waves for this analysis---2001 and 2012. Across all age groups, the prevalence of physical limitations and ADL disability are higher in 2012 than in 2001. Self-reported diabetes is more prevalent in 2012 compared with 2001, as is hypertension and obesity. The age-specific 2012 populations are more likely to have received some formal education, less likely to report ever having smoked and more likely to have visited a physician in the past 12 months. Across nearly all ADL items, prevalence is higher in the 2012 wave than the 2001 wave. Childhood socioeconomic conditions (measured by the presence of household toilet facilities before age 10 years[@R40]) show slight improvements over successive cohorts of 60--69 and 70--79 year-olds, while the proportion reporting a serious childhood illness remained stable. Cognitive status, as measured by the Cross-Cultural Cognitive Examination test,[@R8] suggests that successive cohorts were substantially more likely to have normal cognitive status and less likely to be cognitively impaired.

Age 50--59 {#s3-1}
----------

The top panel of [table 1](#T1){ref-type="table"} and the top panels of [figures 1--3](#F1 F2 F3){ref-type="fig"} compare partial LE and DFLE in ages 50--59 between two 10-year cohorts: those born between 1942 and 1951 (observed in the period 2001--2003), and those born between 1953 and 1962 (the refresher sample added to the third MHAS wave; observed in the period 2012--2015). Overall, individuals born in 1953--1962 lived 0.87 (p\<0.001) fewer active years between ages 50 and 59 than individuals born in 1942--1951, a difference comprised of a 0.54-year (p\<0.001) increase in limited LE and a 0.27-year (p\<0.001) increase in ADL-disabled LE. Active LE for women declined from 56% to 44% as a proportion of partial LE ([figure 3](#F3){ref-type="fig"}), and LE spent physically limited rose from 39% to 48%. Partial female LE between ages 50 and 59 also appears to have declined slightly (−0.15 years, p=0.026). In contrast to women, men did not experience a proportionate expansion of disability in ages 50--59 ([figure 2](#F2){ref-type="fig"}), though LE with an ADL disability increased by 0.15 (p=0.012) years. [Online supplementary table 2](#SP1){ref-type="supplementary-material"} provides partial LE and DFLE estimates in ages 50--59 separately by initial disability state.

![Proportion of remaining LE in active, limited and ADL-disabled life, ages 50--59, 60--69 and 70--79, both sexes combined. The height and area of each bar are proportional to the overall LE in ages 50--59, 60--69 and 70--79, and the differently shaded areas represent the distribution of the LE across disability-free, physically limited and ADL-disabled life. The bars do not necessarily reflect the ordering of these life-years by disability states, as individuals in our analysis can recover and relapse between disability states, so not all years of disability are spent at the end of life. ADL, activities of daily living; LE, life expectancy.](jech-2019-212245f01){#F1}

![Proportion of remaining LE in active, limited and ADL-disabled life, ages 50--59, 60--69 and 70--79, men. The height and area of each bar are proportional to the overall LE in ages 50--59, 60--69 and 70--79, and the differently shaded areas represent the distribution of the LE across disability-free, physically limited and ADL-disabled life. The bars do not necessarily reflect the ordering of these life-years by disability states, as individuals in our analysis can recover and relapse between disability states, so not all years of disability are spent at the end of life. ADL, activities of daily living; LE, life expectancy.](jech-2019-212245f02){#F2}

![Proportion of remaining LE in active, limited and ADL-disabled life, ages 50--59, 60--69 and 70--79, women. The height and area of each bar are proportional to the overall LE in ages 50--59, 60--69 and 70--79, and the differently shaded areas represent the distribution of the LE across disability-free, physically limited and ADL-disabled life. The bars do not necessarily reflect the ordering of these life-years by disability states, as individuals in our analysis can recover and relapse between disability states, so not all years of disability are spent at the end of life. ADL, activities of daily living; LE, life expectancy.](jech-2019-212245f03){#F3}

###### 

Total, active, limited and ADL-disabled life expectancy in ages 50--59, 60--69 and 70--79

  Age 50--59                                                                         
  ------------------------------ --------------------- --------------------- ------- -----------------
  **Birth cohort**                                                                   
                                 1942--1951            1953--1962            Diff    P value of diff
  **Overall**                                                                        
   Total                         9.67 (9.60 to 9.72)   9.60 (9.53 to 9.68)   −0.07   0.128
    Active                       5.90 (5.70 to 6.06)   5.03 (4.73 to 5.32)   −0.87   \<0.001
    Limited                      3.38 (3.24 to 3.57)   3.92 (3.67 to 4.19)   0.54    \<0.001
    ADL disabled                 0.39 (0.32 to 0.45)   0.66 (0.53 to 0.79)   0.27    \<0.001
  **Men**                                                                            
   Total                         9.64 (9.51 to 9.72)   9.69 (9.56 to 9.80)   0.05    0.210
    Active                       6.46 (6.15 to 6.65)   6.35 (5.88 to 6.70)   −0.11   0.616
    Limited                      2.84 (2.66 to 3.10)   2.85 (2.53 to 3.21)   0.01    0.960
    ADL disabled                 0.34 (0.25 to 0.43)   0.49 (0.37 to 0.66)   0.15    0.012
  **Women**                                                                          
   Total                         9.70 (9.62 to 9.78)   9.55 (9.46 to 9.65)   −0.15   0.026
    Active                       5.43 (5.19 to 5.69)   4.21 (3.92 to 4.56)   −1.22   \<0.001
    Limited                      3.83 (3.63 to 4.07)   4.58 (4.29 to 4.88)   0.75    \<0.001
    ADL disabled                 0.44 (0.35 to 0.51)   0.76 (0.59 to 0.93)   0.32    \<0.001
  **Age** **60** **--** **69**                                                       
  **Birth cohort**                                                                   
                                 1932--1941            1943--1952            Diff    P value of diff
  **Overall**                                                                        
   Total                         9.15 (9.02 to 9.26)   9.13 (9.04 to 9.23)   −0.02   0.772
    Active                       4.91 (4.72 to 5.12)   3.78 (3.54 to 3.99)   −1.13   \<0.001
    Limited                      3.67 (3.49 to 3.84)   4.26 (4.07 to 4.46)   0.59    \<0.001
    ADL disabled                 0.57 (0.48 to 0.65)   1.10 (0.97 to 1.23)   0.53    \<0.001
  **Men**                                                                            
   Total                         9.12 (8.94 to 9.29)   9.05 (8.91 to 9.20)   −0.07   0.486
    Active                       5.61 (5.32 to 5.89)   4.79 (4.45 to 5.10)   −0.82   \<0.001
    Limited                      3.12 (2.87 to 3.37)   3.42 (3.20 to 3.68)   0.30    0.002
    ADL disabled                 0.40 (0.31 to 0.51)   0.85 (0.70 to 0.97)   0.45    \<0.001
  **Women**                                                                          
   Total                         9.17 (9.03 to 9.33)   9.19 (9.07 to 9.29)   0.02    0.806
    Active                       4.29 (4.04 to 4.58)   2.95 (2.69 to 3.20)   −1.34   \<0.001
    Limited                      4.17 (3.93 to 4.38)   4.94 (4.67 to 5.17)   0.77    \<0.001
    ADL disabled                 0.71 (0.59 to 0.84)   1.30 (1.16 to 1.49)   0.59    \<0.001
  **Age** **70** **--** **79**                                                       
  **Birth cohort**                                                                   
                                 1922--1931            1933--1942            Diff    P value of diff
  **Overall**                                                                        
   Total                         8.43 (8.24 to 8.65)   8.50 (8.35 to 8.62)   0.07    0.578
    Active                       3.66 (3.38 to 3.95)   2.73 (2.45 to 2.90)   −0.93   \<0.001
    Limited                      3.70 (3.47 to 3.95)   4.13 (3.91 to 4.36)   0.43    \<0.001
    ADL disabled                 1.07 (0.91 to 1.22)   1.64 (1.50 to 1.84)   0.57    \<0.001
  **Men**                                                                            
   Total                         8.39 (8.09 to 8.69)   8.44 (8.22 to 8.62)   0.05    0.782
    Active                       4.40 (4.02 to 4.82)   3.52 (3.16 to 3.77)   −0.88   \<0.001
    Limited                      3.14 (2.83 to 3.46)   3.67 (3.38 to 3.96)   0.53    \<0.001
    ADL disabled                 0.85 (0.68 to 1.02)   1.25 (1.06 to 1.43)   0.40    \<0.001
  **Women**                                                                          
   Total                         8.48 (8.21 to 8.74)   8.55 (8.37 to 8.70)   0.07    0.650
    Active                       2.95 (2.59 to 3.27)   2.05 (1.74 to 2.23)   −0.90   \<0.001
    Limited                      4.24 (3.92 to 4.65)   4.53 (4.24 to 4.84)   0.29    0.120
    ADL disabled                 1.28 (1.04 to 1.54)   1.98 (1.79 to 2.28)   0.70    \<0.001

Data are life expectancy in years unless specified, with the 95% CI in brackets after point estimate. Models adjusted for age and sex (only for overall).

ADL, activities of daily living; Diff, difference.

Age 60--69 {#s3-2}
----------

The middle panel of [table 1](#T1){ref-type="table"} and the middle panels of [figures 1--3](#F1 F2 F3){ref-type="fig"} compare partial DFLE in ages 60--69 across the 1932--1941 and 1943--1952 birth cohorts. In the overall sample, active LE declined by 1.13 years (p\<0.001) across the two birth cohorts, comprised of a 0.59-year increase (p\<0.001) in limited LE and a 0.53-year increase (p\<0.001) in ADL-disabled LE. We find no evidence that total partial LE between ages 60 and 69 has changed between these two cohorts. Active LE for women declined by 1.34 years (p\<0.001), compared with a 0.82-year (p\<0.001) decline for men. The proportion of women's partial LE spent active in these ages declined from 47% to 32% between the two birth cohorts ([figure 3](#F3){ref-type="fig"}), and declined from 61% to 53% for men ([figure 2](#F2){ref-type="fig"}). [Online supplementary table 3](#SP1){ref-type="supplementary-material"} provides partial LE and DFLE estimates in ages 60--69 separately by initial disability state.

Age 70--79 {#s3-3}
----------

The bottom panel of [table 1](#T1){ref-type="table"} and the bottom panels of [figures 1--3](#F1 F2 F3){ref-type="fig"} compare partial LE and DFLE in ages 70--79 between the 1922--1931 and 1933--1943 birth cohorts. Total partial LE between ages 70 and 79 is similar between the two cohorts, though active LE declined by 0.93 years (p\<0.001). The proportion of partial LE spent active in these ages declined from 43% to 32% in the full sample ([figure 1](#F1){ref-type="fig"}). In the more recently born cohort, women expect to spend less than a quarter of these years with no physical limitations ([figure 3](#F3){ref-type="fig"}), and men expect to spend less than half of these years active ([figure 2](#F2){ref-type="fig"}). Men show about a half-year rise in limited LE and a slightly smaller increase in disabled LE between ages 70 and 79 across these two cohorts, and most of the decline in active LE for women is explained by a 0.70-year (p\<0.001) increase in ADL-disabled LE. [Online supplementary table 4](#SP1){ref-type="supplementary-material"} provides partial LE and DFLE estimates in ages 70--79 separately by initial disability state.

Discussion {#s4}
==========

This paper focuses on measuring recent trends in population-level physical health and disability in Mexico. We utilise data from MHAS to investigate how the disability burden of successive cohorts of older adults in Mexico has changed and to determine whether a compression of disability is occurring in Mexico. We, instead, find evidence for a trend of increasing physical limitation and disablement among successive cohorts of older Mexican adults. Across all age groups, more recently born cohorts lived more years with physical limitations and disabilities, with women, in particular, experiencing substantial reductions in active LE across older adult ages.

Our results need to be understood in the context of the larger macroeconomic trends and policy changes occurring during the period covered in our analyses (2001--2015). This period spanned the introduction of a major social programme designed to improve health and well-being in Mexico: Seguro Popular, a publicly funded health insurance scheme designed to target Mexico's large population of uninsured individuals. Seguro Popular had been in existence on a smaller scale since 2003, but coverage gradually expanded to all states during the study period, and by 2012, reached almost complete coverage.[@R42] The introduction of Seguro Popular increased access to and utilisation of diagnostic tests among the older adult population, but evidence on the programme's effectiveness for improving treatment of non-communicable diseases is weaker.[@R43] However, there is the possibility that our results could reflect Seguro Popular's success in increasing survival for individuals in poor health.

Though the policy environment appeared conducive for improvements in population health during the study period, broader social/economic trends were working in the opposite direction. Mexico was hard hit by the 2008 financial crisis, with GDP dropping by 7% in 2009. Drug violence escalated in many regions of Mexico during this time period, and though rates of direct mortality due to violence were low among the older adult population in our study, this spike in drug-related violence led to a decline in foreign investment and tourism income.[@R44] These trends had an outsized effect on older adults, as the undiversified income sources and investments of older adults in Mexico led older individuals to rely heavily on family for financial stability.[@R45]

In conjunction with the rising trends in diabetes, obesity and other chronic non-communicable diseases,[@R4] Mexico has also experienced a rapid increase in survivorship to old ages. [Online supplementary figure 2](#SP1){ref-type="supplementary-material"} shows the proportion of each birth cohort that survived to ages 50, 60 and 70, by gender, based on data from the LaMDa database.[@R48] From the 1940 to 1960 birth cohorts, the proportion of newborns surviving to age 50 rose from just over 50% for men (60% for women) to 73% for men (80% for women). Similar rapid increases in survivorship to ages 60 and 70 are seen across successive birth cohorts. Assuming that mortality is related to frailty (ie, an individual-level latent trait comprising 'health'), cohorts with higher mortality selection into older ages (where fewer cohort members have reached older ages) will be overall less frail, and thus experience fewer disabling conditions.[@R49] Previous theoretical work focusing on Latin America[@R24] has suggested that these changes in survivorship would lead to successive cohorts at higher risk of disability and chronic disease, and our findings seem to support these conclusions. Our findings suggest that these rapid declines in the level of mortality selection into older ages, combined with secular changes in cardiovascular/cardiometabolic diseases and economic conditions, are driving the expansion in limited and disabled LE seen in Mexico.

Limitations and strengths {#s4-1}
-------------------------

In evaluating our results, several limitations need to be considered. The time between interviews varied, with a 2-year period between the 2001 and 2003 waves and a 3-year period between the 2012 and 2015 waves. This difference in time periods may lead us to miss proportionately more short-term transitions in the 2012--2015 period, lowering the predicted transition rates of both onset of limitation/disability and recovery from limitation/disability. On the basis of prior empirical and simulation studies, these downward biases are in large part offsetting, and the 1-year difference in observation periods should still produce unbiased LE and DFLE estimates.[@R36] Individuals who experience a health transition between waves of data collection are assumed to experience only a single transition during the period between surveys, which likely misses shorter-term transitions between health statuses. Measurement of health conditions, such as diabetes, obesity and hypertension, was not available in the 2001 or 2003 waves of MHAS, limiting our ability to explore the role of specific conditions in driving our results.

One of the main strengths of these analyses is the focus on understanding disability change across successive birth cohorts. With a few notable exceptions,[@R21] most work investigating the compression has relied on measuring mortality and disability conditions in a population at different points in time, using data aggregated across many cohorts in a population. Though this approach may be useful for monitoring aggregate trends in population-level disability, these results do not easily translate to the experience of any given cohort of individuals. Disability and mortality are strongly linked to cohort-specific life-course exposures, but period-based models obscure the substantial heterogeneity between birth cohorts.[@R32] Our results centre on measuring how partial total and disability-free LE are changing within age groups over successive birth cohorts, a metric more directly applicable to understanding trends in population health.

Conclusion {#s5}
==========

In Mexico, increasing trends in LE have not led to a compression of disability. This expansion of disability coincided with a rapid rise in obesity, cardiovascular and cardiometabolic conditions in Mexico, and substantial changes in early-life mortality selection and survivorship to older ages. As our analyses were observational in nature, we are unable to determine the relative importance of these overlapping trends. However, the context in which disability expanded in Mexico is by no means unique---many other countries in Latin America, and indeed in many other middle-income contexts worldwide, have seen broadly similar epidemiological and demographic changes in recent decades. Where similar data exists, the methods developed in these analyses could be used to elucidate trends in health over time and across birth cohorts. These results foreshadow a need to more closely monitor cohort trends in adult health across middle-income contexts to understand whether similar expansions of disability are occurring in other countries.

###### What is already known on this subject

-   Increases in life expectancy have gone along with a compression of disability in high-income contexts, but whether this is happening in low-income and middle-income contexts is unknown. Prior theoretical research on Latin America posits the delayed effects of poor childhood conditions, but increasing survivorship to older ages, may lead to successive cohorts at higher risk of morbidity and disability in Latin America.

###### What this study adds

-   Instead of successive generations living longer and with less disability, we found increasing physical limitation and disablement among successive cohorts of older Mexican adults. This expansion of disability overlapped with a rapid rise in obesity, cardiovascular and cardiometabolic conditions in Mexico, and substantial changes in early-life mortality selection and survivorship to older ages. The epidemiological conditions under which disability has expanded in Mexico are similar to those in many other countries in Latin America.
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